Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics

被引:15
作者
Elangovan, Harendran [1 ,2 ]
Rajagopaul, Sashen [1 ]
Williams, Suzanne M. [3 ]
McKillen, Benjamin [1 ,2 ]
Britton, Laurence [1 ,2 ]
McPhail, Steven M. [4 ,5 ]
Horsfall, Leigh U. [1 ,2 ]
Valery, Patricia C. [1 ,6 ]
Hayward, Kelly L. [1 ,2 ]
Powell, Elizabeth E. [1 ,2 ]
机构
[1] Univ Queensland, Translat Res Inst, Fac Med, Ctr Liver Dis Res, Woolloongabba, Qld, Australia
[2] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Woolloongabba, Qld, Australia
[3] Inala Primary Care, Inala, Australia
[4] Queensland Univ Technol, Australian Ctr Hlth Serv Innovat, Brisbane, Qld, Australia
[5] Metro South Hlth, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia
[6] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
FIBROSIS; NAFLD; STEATOHEPATITIS; POPULATION; FEATURES; MARKERS; IMPACT;
D O I
10.1002/hep4.1486
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary care physicians (PCPs) have the primary role in the diagnosis and management of nonalcoholic fatty liver disease (NAFLD), and in selecting patients for referral to a hepatologist for further evaluation. This study aimed to characterize PCP referrals for patients diagnosed with NAFLD at a major referral hospital, and to determine the severity of liver disease and patient pathway following evaluation in secondary care. New patients seen in the hepatology outpatient clinic (HOC) with a secondary care diagnosis of NAFLD were identified from the HOC scheduling database. PCP referrals for these patients were retrieved from the electronic medical records and reviewed by study clinicians, along with the hepatologists' clinic notes and letters. Over a 14-month period, 234 new PCP referrals received a diagnosis of NAFLD, accounting for 20.4% of the total number of new cases (n = 1,147) seen in the HOC. The 234 referrals were received from 170 individual PCPs at 135 practices. Most patients with NAFLD (88.5%) were referred for investigation of abnormal liver enzymes or other clinical concerns, including abnormal iron studies, hepatomegaly, and abdominal pain. Only 27 (11.5%) referrals included an assessment of liver disease severity. Following evaluation in the liver clinic, 175 patients (74.8%) were found to have a low risk of advanced fibrosis, and most (n = 159; 90.9%) were discharged back to their PCP for ongoing follow-up in primary care. Conclusion: In addition to better access to noninvasive fibrosis tests, educational strategies to enhance awareness and recognition of NAFLD as a cause for many of the initial concerns prompting patient referral might improve risk stratification and increase the appropriateness of PCP referrals.
引用
收藏
页码:518 / 526
页数:9
相关论文
共 26 条
  • [1] The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
    Angulo, Paul
    Hui, Jason M.
    Marchesini, Giulio
    Bugianesi, Ellisabetta
    George, Jacob
    Farrell, Geoffrey C.
    Enders, Felicity
    Saksena, Sushma
    Burt, Alastair D.
    Bida, John P.
    Lindor, Keith
    Sanderson, Schuyler O.
    Lenzi, Marco
    Adams, Leon A.
    Kench, James
    Therneau, Terry M.
    Day, Christopher P.
    [J]. HEPATOLOGY, 2007, 45 (04) : 846 - 854
  • [2] Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
    Angulo, Paul
    Kleiner, David E.
    Dam-Larsen, Sanne
    Adams, Leon A.
    Bjornsson, Einar S.
    Charatcharoenwitthaya, Phunchai
    Mills, Peter R.
    Keach, Jill C.
    Lafferty, Heather D.
    Stahler, Alisha
    Haflidadottir, Svanhildur
    Bendtsen, Flemming
    [J]. GASTROENTEROLOGY, 2015, 149 (02) : 389 - +
  • [3] Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting
    Blais, Pierre
    Husain, Nisreen
    Kramer, Jennifer R.
    Kowalkowski, Marc
    El-Serag, Hashem
    Kanwal, Fasiha
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (01) : 10 - 14
  • [4] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    Browning, JD
    Szczepaniak, LS
    Dobbins, R
    Nuremberg, P
    Horton, JD
    Cohen, JC
    Grundy, SM
    Hobbs, HH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
  • [5] Liver Stiffness in Nonalcoholic Fatty Liver Disease: A Comparison of Supersonic Shear Imaging, FibroScan, and ARFI With Liver Biopsy
    Cassinotto, Christophe
    Boursier, Jerome
    de Ledinghen, Victor
    Lebigot, Jerome
    Lapuyade, Bruno
    Cales, Paul
    Hiriart, Jean-Baptiste
    Michalak, Sophie
    Le Bail, Brigitte
    Cartier, Victoire
    Mouries, Amaury
    Oberti, Frederic
    Fouchard-Hubert, Isabelle
    Vergniol, Julien
    Aube, Christophe
    [J]. HEPATOLOGY, 2016, 63 (06) : 1817 - 1827
  • [6] EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
    European Association for the Study of the Liver
    [J]. DIABETOLOGIA, 2016, 59 (06) : 1121 - 1140
  • [7] Local care and treatment of liver disease (LOCATE) - A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care
    El-Gohary, Magdy
    Moore, Mike
    Roderick, Paul
    Watkins, Emily
    Dash, Joanne
    Reinson, Tina
    Newell, Colin
    Kim, Miranda
    Stuart, Beth
    Becque, Taeko
    Sheron, Nick
    [J]. PLOS ONE, 2018, 13 (12):
  • [8] Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
    Estes, Chris
    Razavi, Homie
    Loomba, Rohit
    Younossi, Zobair
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 123 - 133
  • [9] Grattagliano I, 2008, J GASTROINTEST LIVER, V17, P389
  • [10] Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers
    Guha, Indra Neil
    Parkes, Julie
    Roderick, Paul
    Chattopadhyay, Dipanker
    Cross, Richard
    Harris, Scott
    Kaye, Philip
    Burt, Alastair D.
    Ryder, Steve D.
    Aithal, Guruprasad P.
    Day, Christopher P.
    Rosenberg, William M.
    [J]. HEPATOLOGY, 2008, 47 (02) : 455 - 460